用设计型模剂和合成生物制剂解决难以治疗的目标
Colin S Swenson1, Gunasheil Mandava1, Deborah M Thomas1
1Department of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
Chemical reviews
|November 14, 2024
概括
合成稳定和蛋白质模拟剂提供了一种新的方法来准"不可抗药"蛋白质. 这些设计分子将小分子可调性与生物特异性相结合,用于新的治疗开发.
科学领域:
- 化学生物学是化学生物学.
- 治疗开发的治疗方法.
- 药物发现 药物发现
背景情况:
- 许多引起疾病的蛋白质很难用传统药物向.
- 这些"不可抗药"的目标往往具有大型的动态接口,对于信号传输至关重要.
- 小分子和生物制剂在解决这些复杂目标方面存在局限性.
研究的目的:
- 审查合成稳定和蛋白质模仿剂的发展.
- 探索它们的潜力,以准以前无法药物治疗的蛋白质.
- 讨论这些新型治疗方法的设计,选和优化策略.
主要方法:
- 对设计和优化合成类药物的历史和新兴平台的审查.
- 对不同类别的检查:宏环,侧链稳定,非天然模仿剂和合成蛋白模仿剂.
- 针对具有挑战性的生物分子的应用程序的分析.
主要成果:
- 合成稳定和蛋白质模仿剂弥合了小分子和生物之间的差距.
- 这些分子提供合成可调性和生物制剂的结合性质.
- 各种类别在解决难以获得的毒品目标方面表现有前途.
结论:
- 设计型体模拟剂和合成生物制剂代表了一个强大的化学空间,用于无法使用的目标.
- 总结了临床翻译的关键学习和剩余挑战.
- 这些方法对未来的化学探测器和疗法具有重大潜力.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.9K
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
9.5K
相关概念视频
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
